MRSA pre-screening cuts transmissions, saves money

Screening high-risk hospital admissions for Staphylococcus aureus (MRSA) reduced in-hospital MRSA transmissions, saving Memorial Hermann-Texas Medical Center in Houston more than $100,000 a year, according to a study published in the New England Journal of Medicine. Researchers tested a pilot active surveillance program in which staff screened patients admitted to seven intensive care units (ICU) for ventilator-associated pneumonia and bloodstream infections involving MRSA, according to Pharmacy Practice News. If the patients tested positive, staff took additional precautions. Researchers estimate that by avoiding 69 infections over four years, the Memorial-Hermann team annually avoided costs of approximately $398,000 and net savings of about $134,000. Article

Suggested Articles

Epic CEO Judy Faulkner has big concerns about two federal interoperability rules, primarily that the rules undermine patient privacy.

CMS Administrator Seema Verma pushed back on hospitals' resistance to publishing payer-negotiated prices, as now mandated by a federal rule.

New survey insights reveal how health plans can partner with providers in the path toward achieving value-based care success.